Commodore Capital’s RAPT Therapeutics RAPT Stock Holding History

Commodore Capital’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-250,000	Closed	-$8.47M	–	41
2025 Q4	$8.47M	Buy	+250,000	New	+$7.76M	0.56%	31

Commodore Capital's RAPT Position: Q1 2026 in Review

Commodore Capital sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 250,000 shares — an estimated $8.47M sold.

Commodore Capital first reported a position in RAPT in Q4 2025 and held it in 1 quarter. The position peaked at $8.47M in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Commodore Capital reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Commodore Capital sold 250,000 RAPT Therapeutics shares in Q1 2026, an estimated $8.47M.
Commodore Capital first reported a position in RAPT Therapeutics in Q4 2025 and held it in 1 quarter.
Commodore Capital's RAPT Therapeutics position peaked at $8.47M in Q4 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Commodore Capital's 13F filing for Q1 2026, filed 15 May 2026.